Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSeasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia
Malaria Journal, 09/30/09
Asih PBS et al. – The findings demonstrate a slighly higher distribution of drug–resistant alleles during the wet season and support the policy of replacing CQ with ACT in this area, but suggest that SP might still be effective either alone or in combination with other anti–malarials.
Related Articles
Epidemiological Characteristics of Imported and Locally-acquired Malaria in Singapore
Annals, Academy of Medicine, Singapore, 11/03/09
Relevance Score: 94%
Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria
Tropical Medicine & International Health, 11/11/09
Relevance Score: 92%
Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and non-hospitals in south-east Nigeria
Malaria Journal, 10/29/09
Relevance Score: 92%
Plasmodium vivax malaria: An unusual presentation
Indian Journal of Critical Care Medicine, 10/09/09
Relevance Score: 92%
Monkey malaria kills four humans
Trends in Parasitology, 10/07/09
Relevance Score: 92%
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Sponsor
Article Search
Sponsor